Medexus Pharmaceuticals Inc. Stock OTC Markets
Stocks
MEDXF
CA58410Q2036
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
15:44:46 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 3.451 USD | -0.32% |
|
-4.14% | +63.85% |
| 09-24 | Medexus Pharmaceuticals Inc. - Shareholder/Analyst Call | |
| 08-11 | Medexus Pharmaceuticals Inc., Q1 2027 Earnings Call, Aug 11, 2026 |
| Market Cap | 155M 109M 96.68M 90.32M 82.38M 10.47B 157M 1.09B 422M 5.34B 408M 399M 17.16B | P/E 2027 * |
21.4x | P/E 2028 * | 5.94x |
|---|---|---|---|---|---|
| Enterprise Value | 155M 109M 96.68M 90.32M 82.38M 10.47B 157M 1.09B 422M 5.34B 408M 399M 17.16B | EV / Sales 2027 * |
0.95x | EV / Sales 2028 * | 0.79x |
| Free-Float |
93.53% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| MDP | Delayed | |
OTC Markets
| MEDXF | Delayed | |
|
Deutsche Boerse AG
| P731 | Delayed |
Last Transcript: Medexus Pharmaceuticals Inc.
| 1 day | -0.32% | ||
| 1 week | -4.14% | ||
| Current month | -0.32% | ||
| 1 month | -7.23% | ||
| 3 months | -3.33% | ||
| 6 months | +54.06% | ||
| Current year | +63.85% |
| 1 week | 3.42 |  | 3.62 |
| 1 month | 3.42 | | 3.82 |
| Current year | 1.96 | | 3.96 |
| 1 year | 1.8 | | 3.96 |
| 3 years | 1.06 | | 3.96 |
| 5 years | 0.58 | | 3.96 |
| 10 years | 0.58 | | 7.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2018-12-16 | |
Brendon Buschman
DFI | Director of Finance/CFO | - | 2019-05-31 |
| General Counsel | - | 2021-11-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mueller
CHM | Chairman | 66 | 2023-04-10 |
Benoit Gravel
BRD | Director/Board Member | - | 2017-09-21 |
| Director/Board Member | - | 2018-10-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.32% | -4.14% | - | - | 111M | |
| -0.62% | -0.10% | +50.70% | +114.07% | 1,031B | |
| -2.30% | -3.90% | +39.50% | +66.07% | 638B | |
| -0.63% | -1.94% | +12.26% | +74.38% | 462B | |
| -1.03% | -2.88% | +71.35% | +39.69% | 359B | |
| -0.03% | -3.91% | +34.28% | +39.35% | 335B | |
| -1.58% | +0.39% | +17.92% | +25.77% | 273B | |
| -2.02% | -3.20% | +7.60% | +8.38% | 253B | |
| -3.38% | +0.29% | +44.32% | +51.54% | 228B | |
| -1.04% | -2.56% | +32.88% | +96.82% | 185B | |
| Average | -1.05% | -0.36% | +34.53% | +57.34% | 418.21B | |
| Weighted average by Cap. | -0.88% | -0.35% | +38.05% | +69.18% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 163M 115M 102M 95.32M 86.94M 11.05B 166M 1.15B 446M 5.64B 431M 421M 18.11B | 197M 138M 123M 115M 105M 13.31B 199M 1.39B 537M 6.79B 519M 508M 21.81B |
| Net income | 7.47M 5.25M 4.67M 4.36M 3.98M 506M 7.58M 52.71M 20.4M 258M 19.71M 19.29M 829M | 26.89M 18.89M 16.82M 15.71M 14.33M 1.82B 27.3M 190M 73.45M 929M 70.99M 69.46M 2.98B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-01 | US$3.451 | -0.32% | 1,030 |
| 26-09-30 | US$3.462 | -0.80% | 35,326 |
| 26-09-29 | US$3.490 | -3.72% | 23,500 |
| 26-09-25 | US$3.625 | +2.39% | 5,150 |
| 26-09-24 | US$3.541 | -1.65% | 4,950 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDP Stock
- MEDXF Stock
Select your edition
All financial news and data tailored to specific country editions
